Daniel Lynch Spring Works Therapeutics, Inc. (SWTX) insider trading activity

Daniel Lynch is Director of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 82,944 shares of SWTX, which is worth approximately $4.79 Million. The most recent transaction as insider was on Feb 20, 2025, when has been sold 47,600 shares (Common Stock) at a price of $60.69 per share, resulting in proceeds of $2,888,844. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.9K

72.89% 3M change

72.52% 12M change

Total Value Held $4.79 Million

DANIEL LYNCH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 20 2025	SELL Open market or private sale	$2,888,844 $60.69 p/Share	47,600 Reduced 36.46%	82,944 Common Stock
Feb 14 2025	SELL Open market or private sale	$24,000 $60.0 p/Share	400 Reduced 0.31%	130,544 Common Stock
Feb 10 2025	SELL Open market or private sale	$9,544,500 $54.54 p/Share	175,000 Reduced 57.2%	130,944 Common Stock
May 16 2024	BUY Grant, award, or other acquisition	-	4,095 Added 1.32%	305,944 Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	4,648 Added 1.52%	301,849 Common Stock
May 19 2022	BUY Grant, award, or other acquisition	-	4,818 Added 1.6%	297,201 Common Stock
May 20 2021	BUY Grant, award, or other acquisition	-	1,106 Added 0.38%	292,383 Common Stock

Also insider at

BLUE

bluebird bio, Inc. Healthcare

Director

TSVT

2seventy bio, Inc. Healthcare

Daniel Lynch

Director

Stamford,, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Value

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to SpringWorks Therapeutics, Inc.

Track Activities on SWTX

Account